Follow-Up Efficacy Data of Imetelstat in Lower-Risk MDS

Opinion
Video

Eytan M. Stein, MD, reviews recent follow-up data from the IMerge trial investigating imetelstat in patients with lower-risk myelodysplastic syndrome.

Recent Videos
Solly Chedid, MD, and Jamie Koprivnikar, MD
Related Content